Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-040165
Filing Date
2023-11-09
Accepted
2023-11-09 19:48:36
Documents
1
Period of Report
2022-11-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4148
  Complete submission text file 0001493152-23-040165.txt   5685
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Mazur Leonard L (Reporting) CIK: 0001463414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41210 | Film No.: 231394271

Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Issuer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations